secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeloc Technologies, Inc (LCTC)
CIK:        0001493137
Form:       8-K
Filed at:   2024-07-26T23:59:59+00:00
Accession:  0001079973-24-001110
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifeloc raises $798K via private placement, appoints new director, secures $750K credit line
--------------------------------------------------------------------------------

- Issued 210,000 shares at $3.80 to EDCO Partners, raising $798K; EDCO now holds 77.5% of common stock.
- Robert Greenlee resigned from board; replaced by Adam Kashenberg, CEO of Colorado Biolabs, effective July 23.
- Obtained $750K line of credit from Citywide Banks on July 19, 2024.
- Plans beta testing of saliva THC test (SpinDx) in 2024, targeting commercial launch in 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1493137/000107997324001110/0001079973-24-001110-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1493137/000107997324001110/lctc_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-24-001110

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer